Clomipramine Treatment for Self-Injurious Behavior of Individuals with Mental Retardation: A Double-Blind Comparison with Placebo.

Lewis, Mark H.; And Others

Notes FAQ Contact Us

Back to results

ERIC Number: EJ524480

Record Type: Journal

Publication Date: 1996

Pages: N/A

Abstractor: N/A

ISBN: N/A

ISSN: ISSN-0895-8017

EISSN: N/A

Clomipramine Treatment for Self-Injurious Behavior of Individuals with Mental Retardation: A Double-Blind Comparison with Placebo.

Lewis, Mark H.; And Others

American Journal on Mental Retardation, v100 n6 p654-65 May 1996

The efficacy of the serotonin uptake inhibitor clomipramine in treatment of self-injurious behavior (SIB) was tested using a double-blind, placebo-controlled crossover trial in eight adults with severe/profound mental retardation. Clomipramine treatment was associated with significant improvement in the frequency of SIB, SIB intensity, and frequency of stereotypy and compulsions. (Author/DB)

Descriptors: Adults, Behavior Change, Behavior Problems, Drug Therapy, Mental Retardation, Outcomes of Treatment, Pharmacology, Self Injurious Behavior

Publication Type: Journal Articles; Reports - Research

Education Level: N/A

Audience: Researchers

Language: English

Sponsor: N/A

Authoring Institution: N/A

Grant or Contract Numbers: N/A